Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical company which develops medicines for autoimmune and inflammatory diseases. Its programs include OD-001, an oral small-molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, and OD-002, an oral small-molecule inhibitor of solute carrier family 15 member 4, or SLC15A4. The company was founded by Gary D. Glick, Melissa Merrick and David L. Pompliano in April 2021 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Odyssey Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Odyssey Therapeutics Inc market cap is $810.92M.
What is the 52-week high for Odyssey Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Odyssey Therapeutics Inc 52 week high is $20.30 as of May 28, 2026.
What is the 52-week low for Odyssey Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Odyssey Therapeutics Inc 52 week low is $15.35 as of May 28, 2026.
What is Odyssey Therapeutics Inc stock price today?
Odyssey Therapeutics Inc stock price today is $17.92.
What was Odyssey Therapeutics Inc stock price yesterday?
Odyssey Therapeutics Inc stock price yesterday was $17.19.
What is the 50-day moving average of Odyssey Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Odyssey Therapeutics Inc 50-day moving average is $17.42.